AI assistant
Sending…
BXP, Inc. — Director's Dealing 2011
Mar 1, 2011
30463_dirs_2011-03-01_499a53b5-10aa-4940-b75b-48175854b6dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON PROPERTIES INC (BXP)
CIK: 0001037540
Period of Report: 2011-02-28
Reporting Person: LINDE DOUGLAS T (Director, President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-28 | Common Stock, par value $.01 | M | 40000 | $32.62 | Acquired | 70086.7471 | Direct |
| 2011-02-28 | Common Stock, par value $.01 | S | 40000 | $95.056 | Disposed | 30086.7471 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-28 | Employee Stock Option (right to buy) | $32.62 | M | 40000 | Disposed | 2012-01-17 | Common Stock (40000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $.01 | 700 | Indirect |
| Common Stock, par value $.01 | 700 | Indirect |
| Common Stock, par value $.01 | 2100 | Indirect |
Footnotes
F1: Represents the weighted average sale price. These shares were sold in multiple transactions at sale prices ranging from $94.8219 to $95.4, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2: The option vested in three equal annual installments beginning on January 17, 2003.
More from BXP, Inc.
Regulatory Filings
2026
May 22
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 2
Annual Report
2026
Feb 27
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 17